loader image
Sunday, December 21, 2025
70.6 F
McAllen
- Advertisement -

Why Do Some People Get Dementia in Middle Age?

Translate to Spanish or other 102 languages!

Key protein changes could trigger frontotemporal dementia in middle age, a recent study has found. Image for illustration purposes
Key protein changes could trigger frontotemporal dementia in middle age, a recent study has found. Image for illustration purposes
- Advertisement -
  • A new study from UC San Francisco may offer the first clear biological markers for frontotemporal dementia, a condition that often affects people in midlife and is difficult to diagnose.
  • By analysing spinal fluid from patients with inherited frontotemporal dementia, researchers uncovered protein changes linked to RNA regulation and brain connectivity; early indicators that could lead to earlier, more accurate diagnosis.
  • These findings could open the door to precision treatments and expanded access to clinical trials for those living with the disease.

Dementia typically affects older adults, so when it appears in middle age it can be difficult to identify.

Follow the link below to Medical News today for the full story:

https://www.medicalnewstoday.com/articles/why-do-some-people-get-dementia-in-middle-age

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 
- Advertisement -
×